Placement of 4-Fluoroamphetamine into Schedule I... On March 2, 2021, HHS provided DEA a scientific and medical evaluation (dated March 2, 2021) entitled "BASIS FOR THE RECOMMENDATION TO PLACE 4-FLUOROAMPHETAMINE IN SCHEDULE I OF THE.
BASIS FOR THE RECOMMENDATION TO PLACE 4-FLUOROAMPHETAMINE IN SCHEDULE I OF THE CONTROLLED SUBSTANCES ACT... EVALUATING 4-FLUOROAMPHETAMINE UNDER THE EIGHT FACTORS ... for Abuse of 4-Fluoroamphetamine..